Fusion inhibition--a major but costly step forward in the treatment of HIV-1

N Engl J Med. 2003 May 29;348(22):2249-50. doi: 10.1056/NEJMe030042.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Drug Costs
  • Enfuvirtide
  • HIV Envelope Protein gp41 / adverse effects
  • HIV Envelope Protein gp41 / economics
  • HIV Envelope Protein gp41 / therapeutic use*
  • HIV Fusion Inhibitors / adverse effects
  • HIV Fusion Inhibitors / economics
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • Humans
  • Peptide Fragments / adverse effects
  • Peptide Fragments / economics
  • Peptide Fragments / therapeutic use*
  • RNA, Viral / blood
  • United States

Substances

  • HIV Envelope Protein gp41
  • HIV Fusion Inhibitors
  • Peptide Fragments
  • RNA, Viral
  • Enfuvirtide